Trademarkia Logo

United Kingdom

£
Trademark Search
RELOYUS

View On IPO.GOV.UK

Registered

on 17 Aug 2018

Last Applicant/ Owned by

Celgene Corporation

86 Morris Avenue, Summit, New Jersey 07901, United States of America

, ,

Serial Number

UK00003332423 filed on 17th Aug 2018

Registration Number

UK00003332423 registered on
2th Nov 2018

Correspondent Information

Sipara Limited

Rochester House, Eynsham Road, Farmoor

Oxford,

OX2 9NH

RELOYUS

pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system.

Mark Details

Serial Number

UK00003332423

Mark Type

Word

Kind of mark

Individual